EUVIMEDEUVIMED entdecken
Crossref

Association of ANGPT2 and NOS3 Gene Variants With Esophageal Variceal Progression in HCV‐Induced Cirrhosis

Omnia S Nabih, Mohamed Abdel-Samiee iD, Marwa A Tahoon, Elaf Abozeid, Heba Demerdash iD, Fatma Omar Khalil, Randa M Seddik, Marwa L Helal, Gamalat A El Gedawy, HalaA E Khalil, Badawy W AboBakr Yossef, Ahmed B Zaid iD und 1 weitere

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Omnia S Nabih und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, National liver institute, Menoufia university, Shebin El-kom, Egypt. Hauptthemen laut MEDLINE: Liver Cirrhosis, Nitric Oxide Synthase Type III, Polymorphism, Single Nucleotide, Esophageal and Gastric Varices. Die Arbeit nennt 33 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophageal varices (EV) are observed in 60%–85% of patients with decompensated cirrhosis at the time of diagnosis and in 30%–40% of patients with compensated cirrhosis. Hemorrhaging from these varices is a critical medical event and is associated with a mortality rate of approximately 40%. Therefore, it is essential to assess varices that show a risk for bleeding and then implement preventive measures. This urgency has sparked interest in several factors, including genetic polymorphisms, that influence the development of EV. To assess the prognostic value of specific single‐nucleotide polymorphisms (SNPs) in ANGPT2 (rs2442598) and NOS3 (rs2070744) genes involved in EVdevelopment. Four‐hundred fifty patients were enrolled: (1) 150 patients with hepatitis C (HCV)‐related cirrhosis and endocscopically detected varices (Group I), (2) 150 patients with HCV‐related cirrhosis and no varices (Group II), and 150 apparently healthy people as controls (Group III). Liver function tests, hepatitis viral markers, complete blood count {CBC}, abdominal ultrasonography, and detection of ANGPT2 ( rs2442598 ) and NOS3 (rs2070744) based on real‐time polymerase chain reaction were obtained for all participants. No significant differences in the genotype distribution or allele frequencies of ANGPT2 (rs2442598) and NOS3 (rs2070744) between patients with or without EV ( p > 0.05) were found. However, significant differences were noted for ANGPT2 rs2442598 in relation to the presence of varices, ascites, Child–Pugh scores, hypertension (HTN), and levels of alanine and aspartate aminotransferase (ALT and AST, respectively; p < 0.05), while other parameters did not show significant differences ( p > 0.05). Similarly, for NOS3 rs2070744 , significant differences were found in Child–Pugh scores, HTN, and levels of ALT and AST ( p < 0.05). The ANGPT2 (rs2442598) variant is a promising noninvasive indicator to confirm the absence of varices with portal hypertension to predict the absence of EV as a complication of cirrhosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisNitric Oxide Synthase Type IIIPolymorphism, Single NucleotideEsophageal and Gastric VaricesAngiopoietin-2Hepatitis C, ChronicGenetic Predisposition to DiseaseHumansMaleFemaleMiddle AgedAdultAgedDisease ProgressionGenotype

Stichwörter der Autor:innen

ANGPT2 (rs 2442598)NOS3 (rs 2070744)esophageal varicessingle‐nucleotide polymorphisms

Substanzen

Nitric Oxide Synthase Type IIIANGPT2 protein, humanAngiopoietin-2NOS3 protein, human

Autor:innen und Institutionen

  • Department of Clinical Pathology, National liver institute, Menoufia university, Shebin El-kom, Egypt.
  • Department of Hepatology and Gastroenterology National Liver Institute, Menoufia University, Shebin El-kom, Egypt.
  • Departmentof Epidemiology and preventive medicine department, National liver institute, Menoufia University, Shebin El-kom, Egypt.
  • Department of Clinical and Molecular Microbiology and Immunology, National Liver Institute, Menoufia University, Shebin El-kom, Egypt.
  • Department of Tropical Medicine, Faculty of Medicine, Menoufia University, Shebin El-kom, Egypt.
  • Department of Clinical Biochemistry and Molecular Diagnostics, National Liver Institute, Menoufia University, Shebin El-kom, Egypt.

ORCID-Profile: Mohamed Abdel-Samiee, Heba Demerdash, Ahmed B Zaid

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Nabih, O. S., Abdel-Samiee, M., Tahoon, M. A., Abozeid, E., Demerdash, H., Khalil, F. O., Seddik, R. M., Helal, M. L., El Gedawy, G. A., E Khalil, H., Yossef, B. W. A., Zaid, A. B., & Elashmawy, M. I. (2025). Association of ANGPT2 and NOS3 Gene Variants With Esophageal Variceal Progression in HCV‐Induced Cirrhosis. Journal of Medical Virology. https://doi.org/10.1002/jmv.70686

Vancouver

Nabih OS, Abdel-Samiee M, Tahoon MA, Abozeid E, Demerdash H, Khalil FO, et al. Association of ANGPT2 and NOS3 Gene Variants With Esophageal Variceal Progression in HCV‐Induced Cirrhosis. Journal of Medical Virology. 2025. doi:10.1002/jmv.70686

BibTeX
@article{Nabih2025,
  author = {Nabih, Omnia S and Abdel-Samiee, Mohamed and Tahoon, Marwa A and Abozeid, Elaf and Demerdash, Heba and Khalil, Fatma Omar and Seddik, Randa M and Helal, Marwa L and El Gedawy, Gamalat A and E Khalil, HalaA and Yossef, Badawy W AboBakr and Zaid, Ahmed B and Elashmawy, Mai I},
  title = {Association of ANGPT2 and NOS3 Gene Variants With Esophageal Variceal Progression in HCV‐Induced Cirrhosis},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70686}
}
Kostenlos starten →